Abraham (Abe) P. Lee is Professor in the Departments of Biomedical Engineering (BME) and Mechanical and Aerospace Engineering (MAE) at the University of California at Irvine in the USA. He also serves as the director of the Micro/nano Fluidics Fundamentals Focus (MF3) Center, a DARPA-industry supported research center currently with more than 10 industrial members. He also served as BME Associate Department Chair for 6 years (2002-2008). Prior to joining the UCI faculty in 2002, he was a Senior Technology Advisor in the Office of Technology and Industrial Relations at the National Cancer Institute in Bethesda, Maryland, and a program manager in the Microsystems Technology Office of the Defense Advanced Research Projects Agency (DARPA) (Arlington, VA). Dr. Lee started his career at Lawrence Livermore National Laboratory and led projects on the development of microtools for the treatment of stroke and biowarfare defense. Dr. Lee received his Ph.D. degree in Mechanical Engineering from the University of California at Berkeley. Over his career, he has developed a series of LOC devices for biomedical and biotechnological applications. His current research is focused on the development of micro electrofluidics and droplet microfluidic platforms for the following applications: biosensors to detect environmental and terrorism threats, point-of-care diagnostics, "smart" nanomedicine for early detection and treatment, automated cell sorting technologies, and tissue engineering and cell-based therapeutics. His research has contributed to the founding of several start-up companies and he also serves as an advisor to companies and government agencies. Dr. Lee currently serves as Editor for the Journal of Microelectromechanical Systems and International Advisory Editorial Board member of Lab on a Chip journal as well as a member of the Technical Program Committee for the MicroTAS conference amongst others. He served as editor of 4 books, edited two special journal issues, and is author of 5 book chapters. He has given more than 100 invited presentations, owns 34 issued US patents and has published over 100 peer reviewed articles in journals and conference proceedings. He is an elected fellow of the American Institute of and Medical and Biological Engineering (AIMBE).